A novel combination of technologies made this possible A European consortium of epilepsy researchers has reported the discovery of a new gene involved in severe childhood epilepsy. Using a novel combination of technologies, including trio ...
There's long been concern that certain drugs taken to control seizures might be unsafe for use by pregnant women, due to potential effects on the fetus. Now, new British research suggests that the drug levetiracetam does not pose a major ...
Tags: Weighs Safety, Epilepsy Drugs, Safety of Epilepsy Drugs in Pregnancy
A new study finds that the epilepsy drug levetiracetam appears not to be associated with thinking, movement and language problems for preschool children born to mothers who took the drug during pregnancy, although the drug valproate was ...
Tags: epilepsy drug, levetiracetam, preschool children health, pregnancy
Electrical stimulation of a specific area of the brain may help boost a person's ability to get through tough times, according to a tiny new study. Researchers implanted electrodes in the brains of two people with epilepsy to learn about ...
Tags: electrical stimulation of brain, get through tough times
The vast majority of epilepsy patients who have brain surgery to treat the seizure disorder find it improves their mood and their ability to work and drive, a new study reveals. Meanwhile, a second study also indicates the procedure is ...
Tags: epilepsy patients, seizure disorder, brain surgery, epilepsy surgery
Deep brain stimulation might help improve the driving ability of people with Parkinson's disease, a new German study suggests. A deep brain stimulator is an implanted device that sends electrical impulses to the brain. With patients who ...
Tags: deep brain stimulation, driving ability, Parkinson's disease
GlaxoSmithKline, the British pharmaceutical giant, says it will stop paying doctors to market its drugs at conferences and will no longer reward sales agents whose physician customers write the most prescriptions. These practices are ...
The U.S. Food and Drug Administration has approved the first device aimed at easing the pain of migraines preceded by aura -- sensory disturbances that occur just before an attack. About a third of migraine sufferers experience auras. ...
Tags: magnet device, pain of migraines, aura
The U.S. Food and Drug Administration has allowed marketing of the Cerena Transcranial Magnetic Stimulator, a device to relieve pain caused by migraines. Christy Foreman, director of the Office of Device Evaluation in the FDA's Center for ...
The RNS device receiced FDA approval via the PMA pathway. NeuroPace (Mountain View, CA) landed FDA PMA approval for its RNS Stimulator, a device that can detect and treat patients suffering from drug-resistant epilepsy. Seizures occur ...
Tags: RNS, FDA approval, PMA pathway, NeuroPace
Another member of the labiatae, or mint, family, thyme is an herb native to the Mediterranean basin and comes in many varieties. There is only one plant, thymus vulgaris, but the composition of the oil distilled from the plant shows ...
US-based NeuroPace has received the US Food and Drug Administration (FDA) premarket approval for its NeuroPace RNS system, designed to treat partial onset seizures that have not been controlled with two or more antiepileptic medications in ...
Tags: RNS System, NeuroPace
The US Food and Drug Administration (FDA) has approved Sunovion Pharmaceuticals' (Sunovion) antiepileptic drug (AED) Aptiom (eslicarbazepine acetate) for the treatment of partial-onset seizures in patients with epilepsy. According to the ...
Tags: FDA, Sunovion, partial-onset seizure, epilepsy
The Center for Tomography Research Laboratory (CTECH Labs) introduced the latest technology in brain scanning at the 6th International IEEE Engineering in Medicine and Biology Society Conference on Neural Engineering at the Sheraton Hotel, ...
Tags: scan, brain, improved, international
Lundbeck, a Denmark-based pharmaceutical company, has obtained the US Food and Drug Administration (FDA) approval for its SABRIL (vigabatrin), an adjunctive treatment option for children 10 and older with refractory complex partial ...